The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2024 | Association of biological sex, race & ethnicity with clinical characteristics and survival in MCL
Yucai Wang, MD, PhD, Mayo Clinic, Rochester, MN, discusses a study evaluating survival outcomes in patients with mantle cell lymphoma (MCL), noting that women tend to have a better overall survival rate compared to men, even after adjusting for other factors. Additionally, the study found that black patients and Hispanic patients do not appear to have a worse prognosis compared to white patients and non-Hispanic patients in terms of survival outcomes. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
